IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $277,000 | +354.1% | 47,386 | +0.9% | 0.00% | – |
Q4 2018 | $61,000 | -47.0% | 46,946 | +41.0% | 0.00% | – |
Q3 2018 | $115,000 | -24.3% | 33,286 | -0.7% | 0.00% | – |
Q2 2018 | $152,000 | +78.8% | 33,511 | +29.6% | 0.00% | – |
Q1 2018 | $85,000 | +32.8% | 25,863 | +57.7% | 0.00% | – |
Q4 2017 | $64,000 | -68.9% | 16,398 | -17.5% | 0.00% | – |
Q3 2017 | $206,000 | +7.3% | 19,869 | +0.9% | 0.00% | – |
Q2 2017 | $192,000 | +120.7% | 19,694 | +53.9% | 0.00% | – |
Q1 2017 | $87,000 | +29.9% | 12,798 | +5.3% | 0.00% | – |
Q4 2016 | $67,000 | -16.2% | 12,151 | +15.7% | 0.00% | – |
Q3 2016 | $80,000 | -2.4% | 10,499 | +4.1% | 0.00% | – |
Q2 2016 | $82,000 | -39.3% | 10,089 | -3.1% | 0.00% | – |
Q1 2016 | $135,000 | -35.4% | 10,416 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $209,000 | – | 10,416 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,208,210 | $16,738,232,000 | 18.66% |
ProQuest Associates IV LLC | 1,962,720 | $14,877,000 | 4.10% |
BVF INC/IL | 1,200,000 | $9,096,000 | 1.71% |
Abingworth LLP | 197,300 | $1,494,000 | 1.43% |
NEXTHERA CAPITAL LP | 305,000 | $2,312,000 | 1.42% |
Cormorant Asset Management, LP | 432,990 | $3,282,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 203,000 | $1,539,000 | 0.25% |
DAFNA Capital Management LLC | 40,000 | $303,000 | 0.21% |
Monashee Investment Management LLC | 50,000 | $379,000 | 0.13% |
Eventide Asset Management | 180,000 | $1,364,000 | 0.08% |